Mellon Service Co. v. Touche Ross & Co.

17 S.W.3d 432, 2000 Tex. App. LEXIS 2929, 2000 WL 553199
CourtCourt of Appeals of Texas
DecidedMay 4, 2000
Docket01-99-00003-CV
StatusPublished
Cited by77 cases

This text of 17 S.W.3d 432 (Mellon Service Co. v. Touche Ross & Co.) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mellon Service Co. v. Touche Ross & Co., 17 S.W.3d 432, 2000 Tex. App. LEXIS 2929, 2000 WL 553199 (Tex. Ct. App. 2000).

Opinion

OPINION

ERIC ANDELL, Justice.

Mellon Service Company, appellant, brought a derivative cause of action as a minority shareholder of BioSpectrum, Inc., fik/a Immuno Modulators Laboratories, Inc. (IML), against Touche Ross & Co., appellee, Granada Corporation, and- Granada Genetics, Inc. (collectively, Granada) for negligence, gross negligence, constructive fraud, tortious interference, conspiracy, breach of a confidential relationship, and violations of the Texas Deceptive Trade Practices Act (DTPA).

We are asked to decide if the trial court erred in granting Touche’s motions for summary judgment On the issues of: (1) limitations; (2) breach of a fiduciary duty; and (3) res judicata and collateral estoppel. We affirm.

Facts

In 1985, IML entered into a stock exchange agreement with Granada. By December, 1986, Granada had exercised its option and obtained 86.31% of IML’s outstanding shares of common stock, making itself the majority shareholder of IML. Granada proceeded to place four of its officers on IML’s board of directors.

On June 29 and 30,1987, IML’s board of directors met to consider an asset purchase offer from Granada Genetics, Inc., a wholly owned subsidiary of Granada. Under the asset purchase agreement, IML would agree to sell substantially all of its assets, including two of IML’s most important products, Agriferon and Equiferon, in exchange for the cancellation of a $2.3 million debt owed to Granada. On June 30, 1987, the board of directors of IML recommended approval and acceptance of the asset purchase offer made by Granada Genetics, Inc.

On July 14, 1987, a special meeting of the shareholders of IML was held to consider whether the asset purchase agreement should be ratified. The six members of the board of directors were present as *435 well as two representatives of Touche. The asset exchange was approved, with Granada voting its 86% in favor and the minority shareholders voting their 14% against.

Standard of Review

Summary judgment is proper only when the movant establishes there is no genuine issue of material fact and it is entitled to judgment as a matter of law. Nixon v. Mr. Property Management Co., 690 S.W.2d 546, 548 (Tex.1985). When a trial court’s order rendering summary judgment does not specify what grounds it relied upon for its ruling, summary judgment will be affirmed on appeal if any of the theories advanced is meritorious. Carr v. Brasher, 776 S.W.2d 567, 569 (Tex.1989).

STATUTE OF LIMITATIONS

In point of error two, Mellon asserts that the trial court erred in rendering summary judgment in favor of Touche on the basis that Mellon’s claims for negligence and gross negligence, civil conspiracy, tortious interference and DTPA violations were barred by a two-year statute of limitations. 1 Mellon filed suit against Touche on July 26, 1989, therefore, the accrual date for each cause of action could be no earlier than July 26, 1987, or the claims would be barred. Touche argues that the event allegedly giving rise to Mellon’s claimed injury was the sale of substantially all of IML’s assets to Granada. It is undisputed that this sale was approved by IML’s shareholders on July 14, 1987.

1.Standard of Review

A defendant seeking summary judgment on the ground of statute of limitations must: (1) prove, when the cause of action accrued; and (2) negate the discovery rule by proving as a matter of law there is no genuine issue of fact about when the plaintiff discovered or should have discovered the nature of the injury. Burns v. Thomas, 786 S.W.2d 266, 267 (Tex.1990). If the movant, Touche, establishes that the statute of limitations bars the action as a matter of law, the non-movant, Mellon, must then adduce summary judgment proof which raises a fact issue to avoid the statute of limitations. KPMG Peat Marwick v. Harrison County Housing Fin. Corp., 988 S.W.2d 746, 748 (Tex.1999).

2. Accrual of the Cause of Action

The general rule is that a cause of action accrues when a wrongful act causes some legal injury, even when the fact of injury is not discovered until later, and even if all of the resulting damages have not yet occurred. S.V. v. R.V., 933 S.W.2d 1, 4 (Tex.1996). The record reflects that Mellon has consistently claimed that the event giving rise to its alleged injury is the sale of substantially all of IML’s assets to Granada. The asset purchase agreement was given final approval by IML’s shareholders at a meeting on July 14, 1987. Mellon was represented by its president and chairman, Hugh Oneal Myers, and by counsel at this meeting, and was aware of the sale. As a matter of law, Mellon’s cause of action accrued when the shareholders voted and approved the asset purchase agreement.

3. The Discovery Rule

The above stated general rule is applied with the exception of the discovery *436 rule. Id. The discovery rule is 'generally applied in two types of cases: fraud or fraudulent concealment, and where the nature of the injury incurred is inherently undiscoverable, but may be objectively verified. Id. at 6. When a cause of action is deferred by the discovery rule, the cause of action does not accrue until the plaintiff knew or should have known of the wrongful act and resulting injury. Id. Even when the discovery rule is applied, the cause of action accrues’when the fact of injury is known, not when the responsible parties are known. Moreno v. Sterling Drug, Inc., 787 S.W.2d 348, 357 (Tex.1990).

Counsel for Mellon sent correspondence to the boards of directors at IML and Granada on July 14, 1987, formally objecting to the asset purchase agreement and requesting that Granada not be allowed to vote due to conflict of interest concerns. This letter, plus the minutes of the shareholder meeting to vote on the asset purchase agreement demonstrate that Mellon had knowledge of the sale of substantially all of IML’s assets to Granada no later than the date of the approval by IML shareholders on July 14,- 1987. The minutes of the July 14, 1987 meeting show that Mellon was present, represented by its president and an attorney, and objected to Granada’s vote on the asset purchase agreement.

Further, Mellon has brought suit on behalf of the corporation IML. IML was aware of the asset purchase agreement even before the shareholders were notified of the offer from Granada. Therefore, Touche has negated the discovéry rule by proving as a matter of.law there is no genuine issue of fact about when Mellon discovered or should have discovered the nature of the injury.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Davenport v. Adu-Lartey
526 S.W.3d 544 (Court of Appeals of Texas, 2017)
Cody Texas, L.P. v. BPL Exploration, Ltd.
513 S.W.3d 522 (Court of Appeals of Texas, 2016)
Sean Ortega v. Young Again Products, Inc.
548 F. App'x 108 (Fifth Circuit, 2013)
in Re Kirk A. Kennedy
Court of Appeals of Texas, 2010
in Re Wayne Ernest Barker, Relator
Court of Appeals of Texas, 2009
James O. Okorafor v. Frank Will Jeffreys
Court of Appeals of Texas, 2009
Sotelo v. Stewart
281 S.W.3d 76 (Court of Appeals of Texas, 2008)
Gillebaard v. BAYVIEW ACRES ASS'N, INC.
263 S.W.3d 342 (Court of Appeals of Texas, 2007)
John Lewis Nowak v. Jeanne Pellis
Court of Appeals of Texas, 2007

Cite This Page — Counsel Stack

Bluebook (online)
17 S.W.3d 432, 2000 Tex. App. LEXIS 2929, 2000 WL 553199, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mellon-service-co-v-touche-ross-co-texapp-2000.